Vaccination Guide for Patients Undergoing Splenectomy
All patients undergoing splenectomy must receive pneumococcal, meningococcal (both MenACWY and MenB), Haemophilus influenzae type b, and annual influenza vaccinations to prevent overwhelming post-splenectomy infection (OPSI), which carries a 30-70% mortality rate. 1, 2
Core Required Vaccinations
Pneumococcal Vaccination
- Administer PCV20 (preferred) or PCV15 as the initial pneumococcal vaccine 2
- If PCV15 is used, follow with PPSV23 at least 8 weeks later 2, 3
- For patients previously vaccinated with PCV13 only, give PCV20 at least 1 year later 2
- Revaccinate with PPSV23 every 5 years for life 4, 1, 2
- The 23-valent polysaccharide vaccine is more than 90% effective in healthy adults under age 55 4
Meningococcal Vaccination
- Administer both MenACWY and MenB vaccines—both are required, not optional 2, 3
- Give MenACWY as 2 doses 8 weeks apart 2, 3
- Give MenB as either a 2-dose or 3-dose series depending on formulation 2, 3
- Revaccinate with MenACWY every 5 years for life 2, 3
- Revaccinate with MenB every 2-3 years if risk remains 2, 3
- Meningococcal infection carries 40-70% mortality in asplenic patients 3
Haemophilus influenzae Type B (Hib)
- Administer 1 single dose of Hib vaccine for previously unvaccinated adults 2, 3, 5
- This is particularly important as phenoxymethylpenicillin prophylaxis does not reliably cover H. influenzae 4
Influenza Vaccination
- All post-splenectomy patients must receive annual inactivated or recombinant influenza vaccine for life 4, 1, 2
- This reduces secondary bacterial pneumonia and sepsis risk by 54% 3
- The vaccine is best avoided in pregnancy 4
Critical Timing Considerations
For Elective/Planned Splenectomy
- Administer all vaccines at least 2 weeks (minimum 14 days) before surgery to ensure optimal antibody response 4, 1, 2, 5
- Ideally, vaccinate 4-6 weeks before surgery if possible 2, 3
- Antibody formation generally takes 9 days, making the 2-week minimum critical 3
For Emergency/Trauma Splenectomy
- Wait at least 14 days post-operatively before vaccinating, as antibody response is suboptimal before this timeframe 1, 2, 3, 6, 5
- Vaccinate as soon as the patient's condition stabilizes after the 14-day period 2
Special Timing Consideration
- Patients who received rituximab in the previous 6 months may have suboptimal vaccine response; vaccination should be reassessed once B-cell recovery has occurred 2
Lifelong Risk and Reimmunization Schedule
Duration of Risk
- The risk of OPSI is lifelong and clinically significant, with cases reported more than 20 years after splenectomy 4, 1, 3
- Most infections occur within the first two years, but up to one-third manifest at least five years later 4
- Streptococcus pneumoniae accounts for approximately 50% of OPSI cases 1, 3
Reimmunization Requirements
- Children under 2 years should be reimmunized after 2 years due to inherently reduced antibody response 4
- Antibody levels may decline more rapidly than expected in asplenic patients, requiring reimmunization as early as three years after the first dose, especially in children with sickle cell disease 4
Additional Preventive Measures Beyond Vaccination
Antibiotic Prophylaxis
- Lifelong prophylactic antibiotics should be offered to all patients, with highest priority in the first 2 years post-splenectomy 4, 1, 2
- Prophylactic oral phenoxymethylpenicillin is the standard agent 4, 1, 6
- For penicillin-allergic patients, offer erythromycin 4
- Patients should keep emergency standby antibiotics (amoxicillin) at home for immediate use at first sign of fever, malaise, or chills 4, 1, 2, 3
Patient Education and Documentation
- Provide written information about lifelong infection risk and issue a Medic-Alert disc and post-splenectomy card indicating asplenic status 4, 1, 2
- Primary care providers must be formally notified of the patient's asplenic status to ensure appropriate ongoing care 4, 1
- Educate patients about the need for emergency department evaluation with fever >101°F (38°C) 2, 3
Special Precautions
- After dog or animal bites, asplenic patients require a 5-day course of co-amoxiclav due to susceptibility to Capnocytophaga canimorsus (DF-2 bacillus) 4, 1, 3
- Malaria prophylaxis is strongly recommended for travelers to endemic areas 1
High-Risk Populations Requiring Extra Vigilance
Children
- Children under 5 years—especially infants—have an infection rate exceeding 10%, much higher than adults (<1%) 4, 1
- Children under 2 years have inherently reduced ability to mount an antibody response 4
- Because of reduced vaccine efficacy in young children, rely initially on prophylactic antibiotics and immunize after the second birthday 4
Other High-Risk Groups
- Patients with sickle cell disease (HbSS, HbSC) are at especially high risk of overwhelming infection 4
- Patients with lymphoproliferative disorders, myeloma, or chronic infections from encapsulated organisms require extra attention 4
- Patients with functional hyposplenism (from sickle cell disease, thalassemia major, coeliac disease, inflammatory bowel disease) require identical preventive measures as surgical splenectomy patients 4, 2
Common Pitfalls to Avoid
- Failing to administer both MenACWY and MenB vaccines—both are required 2, 3
- Forgetting lifelong revaccination schedules—protection wanes and infection risk persists for life 2, 3
- Vaccinating too soon after emergency splenectomy—wait at least 14 days for optimal antibody response 1, 2, 3, 5
- Not providing emergency standby antibiotics—patients need immediate access to antibiotics at home 4, 1, 2, 3
- Failing to notify primary care providers—only 8% of appropriate immunizations are completed in some studies due to lack of coordination 3, 7
- Not educating patients about lifelong risk—patient compliance depends on understanding the 30-70% mortality rate of OPSI 1, 3, 6